Table 7. Effect of eriodictyol on circulatory enzymatic and non-enzymatic antioxidants.

Group	SOD a	CAT b	GPX  c	GST d	GSH e	GR f
Control	4.12 ± 0.14a	3.12 ± 0.25a	31.24 ± 0.14a	3.56 ± 0.03a	42.21 ± 0.06a	57.22 ± 0.14a
DMH	1.98 ± 0.08b	1.75 ± 0.09b	19.21 ± 0.01b	2.02 ± 0.01b	30.12 ± 0.12b	39.32 ± 0.25b
Eriodictyol	4.56 ± 0.12a	3.37 ± 0.14c	32.01 ± 0.02a	3.68 ± 0.12a	43.65 ± 0.08a	59.02 ± 0.16a
Initiation	3.32 ± 0.24c	3.05 ± 0.03c	26.12 ± 0.09c	2.72 ± 0.15c	32.24 ± 0.12c	43.11 ± 0.02c
Post-initiation	3.74 ± 0.14c	3.12 ± 0.11d	27.32 ± 0.05c	2.84 ± 0.22c	38.02 ± 0.04c	44.21 ± 0.07c
Entire period	4.01 ± 0.09d	3.10 ± 0.15d	30.24 ± 0.02d	3.25 ± 0.23d	41.36 ± 0.08d	49.65 ± 0.23d

^aEnzyme required for 50% inhibition of NBT reduction per min per mg of Hb.

^bμmol H₂O₂ utilized per min per mg of Hb.

^cμmoles of GSH utilized per min per mg Hb.

^dnmoles of CDNB-GSH conjugate formed per min per mg Hb.

^emmol per mg of HB.

^fμmoles of NADPH oxidized per min per mg Hb.